|
Science-based pharmaceutical companies largely make their business on prices negotiated with national governments, often year by year. A consistent public relations effort is needed to keep governments and wider
publics aware of the scale of investment needed to research and develop new medicines.
These images are from a documentary video for Glaxo following a new medicine from discovery through to production, and the organisation's efforts to develop new ways of working to slash both the time and the costs
involved.
|
